Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients

Journal of Heart and Lung Transplantation

Volumn 33, Issue 12, 2014, Pages 1312-1314

  McIlvennan, Colleen K ^a   Page, Robert L ^b   Ambardekar, Amrut V ^a   Brieke, Andreas ^a   Lindenfeld, Joann ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 8; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; WARFARIN; ANTIBODY; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10;

ACUTE HEART FAILURE; ADULT; AGED; ANTICOAGULANT THERAPY; BACTEREMIA; CLINICAL ARTICLE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; DEVICE THROMBOSIS; FEMALE; HOSPITAL PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC CARDIOMYOPATHY; LETTER; MALE; MEDICAL DEVICE COMPLICATION; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOSIS; THROMBOSIS PREVENTION; TOTAL QUALITY MANAGEMENT; VERY ELDERLY; VON WILLEBRAND DISEASE; ADVERSE EFFECTS; BLOOD; BLOOD CLOTTING; DRUG EFFECTS; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; IMMUNOLOGY; INCIDENCE; PHYSIOLOGY; RISK FACTOR;

ADULT; AGED; ANTIBODIES; ANTICOAGULANTS; BLOOD COAGULATION; FACTOR X; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HEPARIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; VENTRICULAR DYSFUNCTION, LEFT; WARFARIN;

EID: 84922067790     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.08.022     Document Type: Letter

References (5)

1. R.C. Starling, N. Moazami, and S.C. Silvestry Unexpected abrupt increase in left ventricular assist device thrombosis N Engl J Med 370 2014 33 40
2. J.W. Vandiver, and T.G. Vondracek Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin Pharmacotherapy 32 2012 546 558
3. S. Crow, D. Chen, and C. Milano Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients Ann Thorac Surg 90 2010 1263 1269
4. K.M. Brinkhous, H. Sandberg, and J.B. Garris Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs Proc Natl Acad Sci USA 82 1985 8752 8756
5. C. Kearon, M. Johnston, and K. Moffat Effect of warfarin on activated partial thromboplastin time in patients receiving heparin Arch Intern Med 1998 1140 1143